Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 164.00
-10.40 (-5.96%)
Apr 1, 2025, 5:31 PM IDT
Lineage Cell Therapeutics Revenue
In the year 2024, Lineage Cell Therapeutics had annual revenue of $9.50M USD with 6.19% growth. Lineage Cell Therapeutics had revenue of $2.87M in the quarter ending December 31, 2024, with 37.36% growth.
Revenue
$9.50M
Revenue Growth
+6.19%
P/S Ratio
n/a
Revenue / Employee
$123.36K
Employees
77
Market Cap
346.29M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.50M | 554.00K | 6.19% |
| Dec 31, 2023 | 8.95M | -5.76M | -39.16% |
| Dec 31, 2022 | 14.70M | 10.36M | 238.70% |
| Dec 31, 2021 | 4.34M | 2.52M | 137.73% |
| Dec 31, 2020 | 1.83M | -1.69M | -48.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 982.96M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |